About this page
NPCE — Neuropace
Why Neuropace (NPCE) moved: the last session's move split into the market, its industry, its themes and the part unique to the company, with our latest explained moves and their sources, beside the live chart.
On Friday, November 20, 2026, Neuropace (NPCE) fell 2.33% at the close. Where it came from: Market (SPY) -4.59%, Health Care Equipment & Supplies +0.55%, Factors (6) +0.62%, Unique to NPCE +1.09%. The market drove the decline, but a move unique to NPCE cushioned part of it.
Fell with the market: chipmakers led it lower on Anthropic headlines (Yahoo). The stories that moved the market.
Neuropace (NPCE) last reported earnings on Thursday, November 12, 2026, after the close (SEC 8-K); the next session, Friday, November 13, 2026, NPCE fell 37.10% at the close — why NPCE moved on Nov 13, 2026. Its next report is estimated for about Tuesday, February 9, 2027 (between February 8 and February 10), after the close, from its own rhythm across 11 reports; not yet announced. The earnings calendar.
Explained moves for NPCE:
- Friday, November 13, 2026: NPCE plunged 37.1% after Q3 results and revised full-year guidance; Leerink downgraded the stock (sec.gov, Benzinga)
Each explained move has its own page: Friday, November 13, 2026.
Only on this page: NPCE's split updating every minute while the market is open, which of the 6 factors moved it and by how much, and the catalyst behind its explained move, with sources.
Explore daily moves on this page shows where NPCE's moves came from, session by session — the market, its industry, its themes, its factors and its own part. The month and three-month views are free; six months, the year to date and the full year, with every day's breakdown and its full explanation, are part of TickerTiles Plus.
All stocks: Why stocks moved. The whole market: Market Overview.